Literature DB >> 6140047

Beta 2-adrenoceptor blockade is the basis of guinea-pig bronchial hyper-responsiveness to leukotriene C4 and other agonists.

S Bongrani, G C Folco, R Razzetti, P Schiantarelli.   

Abstract

Four beta-adrenoceptor antagonists, namely (-)-propranolol, (+)-propranolol, ICI-118551 and (+/-)-practolol, were investigated for their effects on leukotriene C4 (LTC4)-induced bronchoconstriction in the anesthetized guinea-pig. (-)-Propranolol was also investigated for its effects on acetylcholine and histamine bronchospasm in the anaesthetized guinea-pig, and on LTC4-induced contractions of guinea-pig isolated trachea and lung parenchyma. The various beta-adrenoceptor antagonists potentiated, dose-dependently, the bronchoconstriction induced by threshold doses of LTC4 and the intensity of the potentiation correlated with the beta 2-blocking capacity possessed by the drugs. (-)-Propranolol potentiated the bronchospasm induced by threshold doses of acetylcholine and histamine but to a lesser degree than the LTC4-induced bronchospasm. The airway hyper-responsiveness induced by (-)-propranolol was unaffected by pretreatment with mepyramine, cyproheptadine, phenoxybenzamine, atropine or indomethacin. The airway hyper-responsiveness induced by (-)-propranolol persisted even in adrenalectomized or reserpine-treated guinea-pigs, although adrenalectomy induced some increase in airway responsiveness. (-)-Propranolol had no effect on LTC4, histamine and acetylcholine-induced contractions of isolated trachea and lung parenchyma. The results show that the airway hyper-responsiveness induced by beta-adrenoceptor antagonists generally correlates with their beta 2-blocking activity. The possibility remains that some other unknown mechanism(s) may also be implicated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6140047      PMCID: PMC2044947          DOI: 10.1111/j.1476-5381.1983.tb10527.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Utilization of changes in pulmonary resistance for the evaluation of bronchodilator drugs.

Authors:  L Diamond
Journal:  Arch Int Pharmacodyn Ther       Date:  1967-07

2.  Potentiation of bronchomotor responses by beta adrenergic antagonists.

Authors:  L Diamond
Journal:  J Pharmacol Exp Ther       Date:  1972-06       Impact factor: 4.030

3.  The use of the in vivo trachea preparation of the guinea-pig to asses drug action on lung.

Authors:  G W James
Journal:  J Pharm Pharmacol       Date:  1969-06       Impact factor: 3.765

4.  Myocardial and local anesthetic actions of beta-adrenergic receptor blocking drugs: relationship to physicochemical properties.

Authors:  J V Levy
Journal:  Eur J Pharmacol       Date:  1968-02       Impact factor: 4.432

5.  The effect of propranolol on airway resistance.

Authors:  A G Macdonald; C G Ingram; R S McNeill
Journal:  Br J Anaesth       Date:  1967-12       Impact factor: 9.166

6.  Evidence for an adrenergic homeostatic bronchodilator reflex mechanism.

Authors:  M W McCulloch; C Proctor; M J Rand
Journal:  Eur J Pharmacol       Date:  1967-12       Impact factor: 4.432

7.  [On the effect of adrenergic beta-receptor-blocking agents on the ventilatory function in obstructive lung diseases].

Authors:  J Meier; H Lydtin; N Zöllner
Journal:  Dtsch Med Wochenschr       Date:  1966-01-28       Impact factor: 0.628

8.  Optical isomers of propranolol.

Authors:  R Howe; R G Shanks
Journal:  Nature       Date:  1966-06-25       Impact factor: 49.962

9.  Effect of propranolol on ventilatory function.

Authors:  R S McNeill; C G Ingram
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

10.  Comparative study of six -adrenoceptive antagonists on airway resistance and heart rate in the guinea-pig.

Authors:  C Advenier; J R Boissier; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1972-04       Impact factor: 8.739

View more
  2 in total

1.  Paf-acether-induced death in mice: involvement of arachidonate metabolites and beta-adrenoceptors.

Authors:  M Criscuoli; A Subissi
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

Review 2.  Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists.

Authors:  H O Heuer
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.